Ondine Biomedical
Roger manages Ondine’s regulatory and clinical programs, working extensively with the FDA, Health Canada, and the EU to obtain regulatory approvals. Prior to joining the company, he practiced as a physician and surgeon in Seattle and directed a clinical research organization for pharmaceutical and medical device clinical trials.
This person is not in any offices
Ondine Biomedical
1 followers
Ondine is dedicated to development of non-antibiotic anti-infective therapies for a broad spectrum of bacterial, viral & fungal infections. MRSA, Chronic Sinusitis, Dental Health, Mother-to-Child HIV Transmission. http://www.ondinebio.com